Emily Letton | News Reporter

Articles and archive:

Analysis | Cell & Gene Therapy | Contamination Control | Design & Build | Digital | Distribution | Dosage Forms | Drug Delivery | Finance | Finished Product | Hi Tech Manufacturing | Ingredients | Logistics | Manufacturing | Marketing | Media | Microbiology | Packaging | Pharma 5.0 | Pharmaceutical | Regulatory | Research & Development | Sustainability | Training & Education

Emily covers the ever-changing pharma landscape and innovative ingredients from the supplement sector, with particular interest in sports nutrition and the policies and regulations shaping the market

Emily Letton

Profile

Emily is the Scientific Reporter for Nutraceutical Business Review and Manufacturing Chemist. Emily has a background in Biomedical Science and Genetics and a Master’s degree in Journalism from Oxford Brookes University. When she’s not reporting on the latest news, you'll find her in a boat on the river.

 

Related content

Manufacturing
Lonza Capsugel launches nitrite testing service for nitrosamine risk management

Lonza Capsugel launches nitrite testing service for nitrosamine risk management

The company has introduced an integrated nitrite testing and regulatory support service to help pharma manufacturers assess nitrosamine risks associated with empty capsules
Manufacturing
Recipharm and CanVirex partner on scalable oncolytic virus manufacturing

Recipharm and CanVirex partner on scalable oncolytic virus manufacturing

Recipharm will develop a scalable Vero cell/measles virus manufacturing process for CanVirex’s IL-12-expressing oncolytic virus platform targeting advanced solid tumours
Finance
Roche signs $2bn Atavistik Bio deal for allosteric drug discovery

Roche signs $2bn Atavistik Bio deal for allosteric drug discovery

Roche and Atavistik Bio will use the biotech’s AMPS platform to discover oral small-molecule treatments for cardiovascular, renal and metabolic diseases
Research & Development
Vilnius University develops photoredox method to accelerate drug discovery

Vilnius University develops photoredox method to accelerate drug discovery

A new C–H functionalisation method could help medicinal chemists rapidly generate drug analogues from simple aromatic compounds using a universal chemical intermediate
Regulatory
AstraZeneca’s Trixeo approved in EU for asthma

AstraZeneca’s Trixeo approved in EU for asthma

The single-inhaler triple therapy becomes the first treatment of its kind approved in the EU for asthma patients aged 12 and older, expanding its existing COPD indication
Research & Development
Daiichi Sankyo expands Turbine collaboration to accelerate ADC discovery

Daiichi Sankyo expands Turbine collaboration to accelerate ADC discovery

The expanded partnership will use Turbine’s vLab virtual biology platform to simulate ADC responses and prioritise experiments across Daiichi Sankyo’s oncology pipeline
Finance
Isotope refinery, cold chain M&A and DARPA deals: pharma finance roundup

Isotope refinery, cold chain M&A and DARPA deals: pharma finance roundup

From a £10m isotope refinery raise to Copeland's Dickson acquisition and a $14m DARPA-backed red blood cell programme, here is this week's biggest pharma manufacturing and life sciences funding news
Manufacturing
Gaelic and Athlone Labs launch dual-source Beta-Lactam strategy

Gaelic and Athlone Labs launch dual-source Beta-Lactam strategy

The pair have aligned their manufacturing processes following their 2025 acquisition, enabling dual-source production of oral Beta-Lactam antibiotics from two Irish sites
Ingredients
From classroom to cleanroom: how a teacher built Ireland's pioneering dronabinol pharma company

From classroom to cleanroom: how a teacher built Ireland's pioneering dronabinol pharma company

Dunbar Pharma CEO Leah Fletcher talks to Emily Letton at Manufacturing Chemist about regulatory hurdles, the chemistry of cannabinoid API and why plant-derived dronabinol beats synthetic
Research & Development
NIS and Proteos launch TrueCourse Biosciences to support AI drug discovery

NIS and Proteos launch TrueCourse Biosciences to support AI drug discovery

NanoImaging Services and Proteos have launched TrueCourse Biosciences, combining protein production, structural biology and biophysical analysis to support experimental validation of AI-designed drug candidates
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development
ConsoneAI's DioScor predicts cross-species drug toxicity in 90 seconds accounting for sex and ethnicity

ConsoneAI's DioScor predicts cross-species drug toxicity in 90 seconds accounting for sex and ethnicity

The RSC Emerging Technologies finalist integrates machine learning across seven species and multiple organ systems — with early adopters estimating potential reductions in carcinogenicity preclinical costs from £4m to £900,000
Drug Delivery
Bespak and Upperton partner to deliver integrated nasal drug-device combination product development pathway

Bespak and Upperton partner to deliver integrated nasal drug-device combination product development pathway

The collaboration merges Bespak's nasal device portfolio with Upperton's formulation and clinical manufacturing expertise, supporting liquid, soft mist and dry powder formats as CNS and nose-to-brain delivery applications accelerate